Ondansetron for symptoms of gastroparesis in patients with chronic kidney disease undergoing hemodialysis

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 72 人开始时间: 2024年7月12日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1) Patients with chronic kidney failure who come to use hemodialysis services at the Hemodialysis Center Faculty of Medicine Chiang Mai University (March - December 2024)
•2) Have symptoms of early satiety and distension after meals. (postprandial fullness) and abnormal symptoms caused by the stomach (nausea, distension, bloating, and epigastric pain) for a period of at least 3 months.
•3) Have an average total score from the Gastroparesis Cardinal Symptom Index (GCSI) questionnaire that is greater than or equal to 2 points.

•1) Unable to reposition in a supine position.
•2) Unable to communicate to answer questionnaires.
•3) Ever stomach surgery or stomach cancer
•4) Use drugs that reduce nausea and vomiting or drugs that increase gastrointestinal function (prokinetic drugs) during the 2 weeks before participating in the study.
•5) There are restrictions on eating before hemodialysis, such as a history of low blood pressure during hemodialysis. or have excess fluid that requires hemodialysis to remove more than 4 kilograms of water
•6) Unable to eat food by mouth
•7) Have nausea and vomiting and cannot eat.
•8) No water or food for less than 6 hours.

发起方